Bulletin from the Annual General Meeting in Oncopeptides AB (publ)
Stockholm, Sweden – June 28, 2022 – The Annual General Meeting in Oncopeptides AB (publ) (ONCO) was held on Tuesday, 28 June 2022. At the Annual General Meeting, the following principal resolutions were passed.· The presented annual report was adopted, and the members of the Board of Directors and the CEOs were discharged from liability in respect of the financial year 2021. · It was resolved to carry forward the result for the year in accordance with the Board of Directors’ proposal. · The proposed remunerations to the Board of Directors, the Board of Directors’ committees and the